Bellevue Group AG
- SEC CIK
- 0001674546
- Latest filing
- Aug 14, 2026
Holdings in Q4 2022
Holdings as of Dec 31, 2022, filed Feb 14, 2023. Long positions only; changes compare share counts with Q3 2022.
- Positions
- 171
- −5 vs. Q3 2022
- Portfolio value
- $7.53B
- +$566.9M (+8.1%) vs. Q3 2022
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| IONSIonis Pharmaceuticals Inc | COM | 9,743,900 | $368.0M | 4.9% | +280,500+3.0% | Added | History |
| ARGXArgenx SE | SPONSORED ADR | 911,100 | $345.2M | 4.6% | −8,246−0.9% | Reduced | History |
| NBIXNeurocrine Biosciences Inc | Stock | 2,773,294 | $331.2M | 4.4% | −81,852−2.9% | Reduced | History |
| VRTXVertex Pharmaceuticals Inc | Stock | 1,096,028 | $316.5M | 4.2% | −62,098−5.4% | Reduced | History |
| MRNAModerna, Inc. | Stock | 1,582,328 | $284.2M | 3.8% | +22,527+1.4% | Added | History |
| ISRGIntuitive Surgical Inc | COM NEW | 957,086 | $254.0M | 3.4% | +58,994+6.6% | Added | History |
| INCYIncyte Corp | COM | 2,956,977 | $237.5M | 3.2% | +212,700+7.8% | Added | History |
| ALNYAlnylam Pharmaceuticals, Inc. | COM | 921,213 | $218.9M | 2.9% | −35,549−3.7% | Reduced | History |
| ABTAbbott Laboratories | Stock | 1,684,479 | $184.9M | 2.5% | +114,628+7.3% | Added | History |
| BSXBoston Scientific Corp | Stock | 3,902,924 | $180.6M | 2.4% | +98,877+2.6% | Added | History |
| ITCIIntra-Cellular Therapies, Inc. | COM | 3,342,236 | $176.9M | 2.3% | +12,957+0.4% | Added | History |
| MYOVMyovant Sciences Ltd. | COM | 5,910,639 | $159.4M | 2.1% | −2,0000.0% | Reduced | History |
| JAZZJazz Pharmaceuticals plc | SHS USD | 756,636 | $120.5M | 1.6% | −67,203−8.2% | Reduced | History |
| SYKStryker Corp | Stock | 492,234 | $120.3M | 1.6% | +15,302+3.2% | Added | History |
| AXNXAxonics, Inc. | COM | 1,906,461 | $119.2M | 1.6% | −286,739−13.1% | Reduced | History |
| UNHUnitedHealth Group Inc | Stock | 224,294 | $118.9M | 1.6% | −72,460−24.4% | Reduced | History |
| RVMDRevolution Medicines, Inc. | COM | 4,855,162 | $115.6M | 1.5% | +175,000+3.7% | Added | History |
| AGIOAgios Pharmaceuticals, Inc. | COM | 4,056,792 | $113.9M | 1.5% | −2,0000.0% | Reduced | History |
| SAGESage Therapeutics, Inc. | COM | 2,969,278 | $113.2M | 1.5% | −1,4000.0% | Reduced | History |
| DXCMDexcom Inc | COM | 988,476 | $111.9M | 1.5% | +128,016+14.9% | Added | History |
| PODDInsulet Corp | Stock | 345,780 | $101.8M | 1.4% | −28,173−7.5% | Reduced | History |
| INSPInspire Medical Systems, Inc. | COM | 401,742 | $101.2M | 1.3% | −260.0% | Reduced | History |
| DHRDanaher Corp | Stock | 366,350 | $97.2M | 1.3% | −1,085−0.3% | Reduced | History |
| SRPTSarepta Therapeutics, Inc. | COM | 693,209 | $89.8M | 1.2% | −62,689−8.3% | Reduced | History |
| BDXBecton Dickinson & Co | Stock | 331,560 | $84.3M | 1.1% | −3,278−1.0% | Reduced | History |
| TNDMTandem Diabetes Care Inc | COM NEW | 1,791,450 | $80.5M | 1.1% | +225,435+14.4% | Added | History |
| CLDXCelldex Therapeutics, Inc. | COM NEW | 1,800,000 | $80.2M | 1.1% | 00.0% | Unchanged | History |
| HCAHCA Healthcare, Inc. | COM | 331,306 | $79.5M | 1.1% | +45,517+15.9% | Added | History |
| EWEdwards Lifesciences Corp | Stock | 1,064,131 | $79.4M | 1.1% | +38,416+3.7% | Added | History |
| ELVElevance Health, Inc. | Stock | 149,421 | $76.6M | 1.0% | −53,071−26.2% | Reduced | History |
| ARVNArvinas, Inc. | COM | 2,150,412 | $73.6M | 1.0% | −40,350−1.8% | Reduced | History |
| OMOutset Medical, Inc. | COM | 2,843,679 | $73.4M | 1.0% | +426,223+17.6% | Added | History |
| OPCHOption Care Health, Inc. | COM NEW | 2,430,422 | $73.1M | 1.0% | −198,750−7.6% | Reduced | History |
| INSMINSMED Inc | COM PAR $.01 | 3,277,207 | $65.5M | 0.9% | +62,503+1.9% | Added | History |
| EXASExact Sciences Corp | COM | 1,312,015 | $65.0M | 0.9% | +182,362+16.1% | Added | History |
| CRLCharles River Laboratories International, Inc. | COM | 289,977 | $63.2M | 0.8% | +26,984+10.3% | Added | History |
| RLAYRelay Therapeutics, Inc. | COM | 4,204,820 | $62.8M | 0.8% | 00.0% | Unchanged | History |
| MOHMolina Healthcare, Inc. | COM | 186,014 | $61.4M | 0.8% | −54,576−22.7% | Reduced | History |
| MGNXMacrogenics Inc | COM | 8,979,913 | $60.3M | 0.8% | +1,654,399+22.6% | Added | History |
| APLSApellis Pharmaceuticals, Inc. | COM | 1,104,217 | $57.1M | 0.8% | +96,773+9.6% | Added | History |
| CNCCentene Corp | Stock | 693,558 | $56.9M | 0.8% | +165,118+31.2% | Added | History |
| HUMHumana Inc | Stock | 110,539 | $56.6M | 0.8% | −23,667−17.6% | Reduced | History |
| EVHEvolent Health, Inc. | CL A | 1,983,653 | $55.7M | 0.7% | +114,598+6.1% | Added | History |
| SILKSilk Road Medical Inc | COM | 1,012,523 | $53.5M | 0.7% | −34,833−3.3% | Reduced | History |
| PACBPacific Biosciences of California, Inc. | COM | 6,478,925 | $53.0M | 0.7% | +1,039,374+19.1% | Added | History |
| CICigna Group | Stock | 158,621 | $52.6M | 0.7% | −30,080−15.9% | Reduced | History |
| AMEDAmedisys Inc | COM | 613,512 | $51.3M | 0.7% | +14,578+2.4% | Added | History |
| SWAVShockwave Medical, Inc. | COM | 247,616 | $50.9M | 0.7% | −28,516−10.3% | Reduced | History |
| GMEDGlobus Medical Inc | Stock | 680,180 | $50.5M | 0.7% | +33,017+5.1% | Added | History |
| PENPenumbra Inc | COM | 225,817 | $50.2M | 0.7% | +36,043+19.0% | Added | History |
| FATEFate Therapeutics Inc | COM | 4,861,279 | $49.1M | 0.7% | +1,115,193+29.8% | Added | History |
| MDTMedtronic plc | Stock | 618,420 | $48.1M | 0.6% | +2,494+0.4% | Added | History |
| BIOBio-Rad Laboratories, Inc. | CL A | 111,158 | $46.7M | 0.6% | +9,340+9.2% | Added | History |
| HALOHalozyme Therapeutics, Inc. | COM | 812,700 | $46.2M | 0.6% | −117,800−12.7% | Reduced | History |
| TMOThermo Fisher Scientific Inc. | Stock | 83,329 | $45.9M | 0.6% | +11,185+15.5% | Added | History |
| IDXXIDEXX Laboratories Inc | COM | 108,822 | $44.4M | 0.6% | 00.0% | Unchanged | History |
| EXELExelixis, Inc. | COM | 2,673,500 | $42.9M | 0.6% | 00.0% | Unchanged | History |
| TMDXTransMedics Group, Inc. | COM | 682,058 | $42.1M | 0.6% | +28,244+4.3% | Added | History |
| PFEPfizer Inc | Stock | 788,673 | $40.4M | 0.5% | +21,373+2.8% | Added | History |
| IQVIQVIA Holdings Inc. | Stock | 183,320 | $37.6M | 0.5% | +23,093+14.4% | Added | History |
| CRSPCRISPR Therapeutics AG | NAMEN AKT | 911,705 | $37.1M | 0.5% | −16,600−1.8% | Reduced | History |
| CDNACareDx, Inc. | COM | 3,168,448 | $36.2M | 0.5% | +567,002+21.8% | Added | History |
| ZBHZimmer Biomet Holdings, Inc. | Stock | 266,296 | $34.0M | 0.5% | +1,026+0.4% | Added | History |
| AXSMAxsome Therapeutics, Inc. | COM | 436,658 | $33.7M | 0.4% | −59,866−12.1% | Reduced | History |
| BNTXBioNTech SE | SPONSORED ADS | 221,080 | $33.2M | 0.4% | +67,500+44.0% | Added | History |
| HRMYHarmony Biosciences Holdings, Inc. | COM | 596,192 | $32.9M | 0.4% | −60,996−9.3% | Reduced | History |
| WVEWave Life Sciences, Inc. | SHS | 4,494,458 | $31.5M | 0.4% | 00.0% | Unchanged | History |
| PRCTPROCEPT BioRobotics Corp | COM | 741,517 | $30.8M | 0.4% | +152,255+25.8% | Added | History |
| VEEVVeeva Systems Inc | Stock | 186,257 | $30.1M | 0.4% | +28,666+18.2% | Added | History |
| ACCDAccolade, Inc. | COM | 3,677,277 | $28.6M | 0.4% | +105,407+3.0% | Added | History |
| ATRCAtriCure, Inc. | COM | 644,109 | $28.6M | 0.4% | +1,662+0.3% | Added | History |
| HCMHUTCHMED (China) Ltd | SPONSORED ADS | 1,780,144 | $28.4M | 0.4% | +22,069+1.3% | Added | History |
| BEAMBeam Therapeutics Inc. | COM | 696,721 | $27.2M | 0.4% | +125,000+21.9% | Added | History |
| ESPREsperion Therapeutics, Inc. | COM | 4,330,264 | $27.0M | 0.4% | +105,000+2.5% | Added | History |
| COOCooper Companies, Inc. | COM NEW | 81,313 | $26.9M | 0.4% | 00.0% | Unchanged | History |
| OMCLOmnicell, Inc. | COM | 518,384 | $26.1M | 0.3% | +104,100+25.1% | Added | History |
| MRSNMersana Therapeutics, Inc. | COM | 4,282,600 | $25.1M | 0.3% | +200,000+4.9% | Added | History |
| ADPTAdaptive Biotechnologies Corp | COM | 2,960,131 | $22.6M | 0.3% | −319,489−9.7% | Reduced | History |
| CSTLCastle Biosciences Inc | COM | 944,312 | $22.2M | 0.3% | +2,441+0.3% | Added | History |
| PHRPhreesia, Inc. | COM | 666,419 | $21.6M | 0.3% | 00.0% | Unchanged | History |
| KZRKezar Life Sciences, Inc. | COM | 3,031,000 | $21.3M | 0.3% | 00.0% | Unchanged | History |
| PRVAPrivia Health Group, Inc. | COM | 900,666 | $20.5M | 0.3% | +385,636+74.9% | Added | History |
| RMDResmed Inc | COM | 98,275 | $20.5M | 0.3% | +13,663+16.1% | Added | History |
| EPIXESSA Pharma Inc. | COM NEW | 7,898,583 | $19.9M | 0.3% | +2,000,000+33.9% | Added | History |
| SRRKScholar Rock Holding Corp | COM | 2,152,025 | $19.5M | 0.3% | 00.0% | Unchanged | History |
| ILMNIllumina, Inc. | COM | 94,907 | $19.2M | 0.3% | +8,980+10.5% | Added | History |
| CVSCVS Health Corp | Stock | 204,205 | $19.0M | 0.3% | −20,909−9.3% | Reduced | History |
| HOLXHologic Inc | COM | 243,171 | $18.2M | 0.2% | −8,241−3.3% | Reduced | History |
| LEGNLegend Biotech Corp | SPONSORED ADS | 354,789 | $17.7M | 0.2% | −270,672−43.3% | Reduced | History |
| ALGNAlign Technology Inc | COM | 79,194 | $16.7M | 0.2% | +4,255+5.7% | Added | History |
| BAXBaxter International Inc | Stock | 320,681 | $16.3M | 0.2% | +1,133+0.4% | Added | History |
| DOCSDoximity, Inc. | CL A | 448,579 | $15.1M | 0.2% | +255,140+131.9% | Added | History |
| GBIOGeneration Bio Co. | COM | 3,627,280 | $14.3M | 0.2% | 00.0% | Unchanged | History |
| TXG10x Genomics, Inc. | CL A COM | 324,746 | $11.8M | 0.2% | +70,612+27.8% | Added | History |
| REGNRegeneron Pharmaceuticals, Inc. | COM | 15,678 | $11.3M | 0.2% | −1,711−9.8% | Reduced | History |
| GILDGilead Sciences, Inc. | Stock | 130,343 | $11.2M | 0.1% | +32,489+33.2% | Added | History |
| NVRONevro Corp | COM | 260,835 | $10.3M | 0.1% | 00.0% | Unchanged | History |
| AMGNAmgen Inc | Stock | 38,939 | $10.2M | 0.1% | −6,257−13.8% | Reduced | History |
| AVTRAvantor, Inc. | COM | 471,621 | $9.95M | 0.1% | −31,386−6.2% | Reduced | History |
| BDTXBlack Diamond Therapeutics, Inc. | COM | 5,400,839 | $9.72M | 0.1% | +683,726+14.5% | Added | History |
Sold out since Q3 2022 (13)
Positions held at the end of Q3 2022 that are gone from this filing.
| Security | Class | Shares in Q3 2022 | Value in Q3 2022 | % of portfolio in Q3 2022 | History |
|---|---|---|---|---|---|
| ABMDAbiomed Inc | COM | 166,355 | $40.9M | 0.6% | History |
| LUNGPulmonx Corp | COM | 173,336 | $2.89M | <0.1% | History |
| RLMDRelmada Therapeutics, Inc. | COM | 53,187 | $1.97M | <0.1% | History |
| NTLAIntellia Therapeutics, Inc. | COM | 30,478 | $1.71M | <0.1% | History |
| NPCENeuroPace Inc | COM | 388,368 | $1.46M | <0.1% | History |
| RGENRepligen Corp | COM | 6,600 | $1.24M | <0.1% | History |
| CRBUCaribou Biosciences, Inc. | COM | 66,300 | $699.0K | <0.1% | History |
| ELEstee Lauder Companies Inc | CL A | 1,348 | $291.0K | <0.1% | History |
| SWKSSkyworks Solutions, Inc. | Stock | 2,100 | $179.0K | <0.1% | History |
| AVLRAvalara, Inc. | COM | 1,300 | $119.0K | <0.1% | History |
| ZTSZoetis Inc. | Stock | 246 | $36.0K | <0.1% | History |
| CTLTCatalent, Inc. | COM | 473 | $34.0K | <0.1% | History |
| NVSTEnvista Holdings Corp | COM | 822 | $27.0K | <0.1% | History |